| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 18,503,360 | 10,094,329 |
| Net decrease in cash and cash equivalents | -293,072 | -3,112,617 |
| Cash and cash equivalents at beginning of period | 13,476,331 | - |
| Cash and cash equivalents at end of period | 13,183,259 | - |
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)